-$3.92 (-1.52%)
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Joaquin Duato |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Current Symbol | JNJ |
| CUSIP | 478160104 |
| CIK | 0000200406 |
| Web | https://www.jnj.com |
| Phone | 732 524 0400 |
| Currency | USD |
| Employees | 141700 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.68 |
| Payout Ratio | 0.60 |
| Current Ratio | 1.03 |
| Quick Ratio | 0.77 |
| Cash Ratio | 0.38 |
Sales & Book Value
| Annual Sales | $94.19B |
| Price / Sales | 6.34 |
| Cash Flow | 7.28 |
| Price / Cash Flow | 34.33 |
| Price / Book | 7.65 |
Price Target and Rating
| Average Stock Price Forecast | $265.00 |
| High Stock Price Forecast | $290.00 |
| Low Stock Price Forecast | $220.00 |
| Forecast Upside/Downside | -4.21% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 40 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $11.03 |
| Trailing P/E Ratio | 29.28 |
| PEG Ratio | -6.64 |
| P/E Growth | -6.64 |
| Net Income | $26.8B |
| Net Margin | 21.83% |
| Pretax Margin | 25.88% |
| Return on Equity | 26.26% |
| Return on Assets | 10.47% |
Financials Score
| AltmanZ Score | 5.20 |
| Piotroski Score | 7.00 |
| Working Capital | 1.46B |
| Total Assets | 200.89B |
| Ebit | 25.75B |
| Market Cap | 620.51B |
| Total Liabilities | 119.71B |
About Johnson & Johnson (NYSE:JNJ) Stock
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. ...
Morgan Stanley, Johnson & Johnson And 3 Stocks To Watch Heading Into Wednesday
2026-07-15 02:29:24
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
This Healthcare Giant Still Checks Every Box for Long-Term Investors
2026-07-14 12:30:20
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) has been one of 2026's quieter winners in large-cap healthcare, and our proprietary model sees room to run.
Wall Street closes higher as cooling inflation lifts chip stocks, rate hopes
2026-07-14 12:25:00
4:20pm: Rate hopes lift markets US stocks finished mostly higher on Tuesday after a softer-than-expected inflation report boosted hopes that the Federal...
A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets
2026-07-14 12:12:27
A $1.4 million nest egg is far above the typical U.S. retirement account balance, but the check it writes each month depends entirely on how the assets are arranged. At a 3.5% yield, the portfolio produces $49,000 a year. At a 10% yield, it produces $140,000. The difference looks simple on a spreadsheet, but it... A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets
2026-07-14 11:55:20
Health care giant Johnson & Johnson (NYSE:JNJ) reports second-quarter financial results on Wednesday before the market opens. Here are the earnings estimates, what experts are saying and key items to watch.
Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
2026-07-14 10:56:28
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.
A Dividend Portfolio That Can Cover the Cost of Living in San Francisco
2026-07-14 10:03:33
San Francisco makes passive income math unforgiving. SmartAsset's 2026 comfort-salary study estimates that a single adult needs about $134,950 in pretax income to live comfortably in the city, among the highest figures in the country. Turning that paycheck into dividend income is not just a yield exercise. The yield an investor reaches for changes both... A Dividend Portfolio That Can Cover the Cost of Living in San Francisco
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
2026-07-14 08:40:20
Johnson & Johnson (NYSE:JNJ) will release its second-quarter earnings report before the opening bell on Wednesday, July 15.
Frequently Asked Questions
What is the current Johnson & Johnson (JNJ) stock price?
Johnson & Johnson(NYSE:JNJ) stock price is $253.85 in the last trading session. During the trading session, JNJ stock reached the peak price of $269.43 while $154.8 was the lowest point it dropped to. The percentage change in JNJ stock occurred in the recent session was --1.52% while the dollar amount for the price change in JNJ stock was -$-3.92.
JNJ's industry and sector of operation?
The NYSE listed JNJ is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector.
Who are the executives of JNJ?
Dirk Brinckman
| Chief Compliance Officer
Timothy Schmid
| Executive Vice President & Worldwide Chairman of MedTech
Joaquin Duato
| Chief Executive Officer & Chairman
Joseph J. Wolk
| Executive Vice President & Chief Financial Officer
Jennifer L. Taubert
| Executive Vice President & Worldwide Chairman of Innovative Medicine
How many employees does JNJ have?
Number of JNJ employees currently stands at 141700. JNJ operates from One Johnson & Johnson Plaza, New Brunswick, NJ 08933, US.
Link for JNJ official website?
Official Website of JNJ is: https://www.jnj.com
How do I contact JNJ?
JNJ could be contacted at phone #732 524 0400 and can also be accessed through its website. JNJ operates from One Johnson & Johnson Plaza, New Brunswick, NJ 08933, US.
How many shares of JNJ are traded daily?
The average number of JNJ shares traded daily for last 3 months was 8.1M.
What is the market cap of JNJ currently?
The market value of JNJ currently stands at $611.07B with its latest stock price at $253.85